A detailed history of Lpl Financial LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 44,780 shares of ACXP stock, worth $36,719. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,780
Previous 53,735 16.67%
Holding current value
$36,719
Previous $120,000 29.17%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$1.83 - $2.62 $16,387 - $23,462
-8,955 Reduced 16.67%
44,780 $85,000
Q2 2024

Aug 07, 2024

BUY
$1.64 - $2.79 $22,140 - $37,665
13,500 Added 33.55%
53,735 $120,000
Q1 2024

May 10, 2024

BUY
$1.94 - $4.81 $51,516 - $127,729
26,555 Added 194.12%
40,235 $98,000
Q4 2023

Feb 14, 2024

BUY
$1.28 - $5.76 $17,510 - $78,796
13,680 New
13,680 $52,000

Others Institutions Holding ACXP

About Acurx Pharmaceuticals, Inc.


  • Ticker ACXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,556,600
  • Market Cap $9.48M
  • Description
  • Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...
More about ACXP
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.